Powering the future of point-of-care diagnostics

Timely and precise diagnosis is essential for effective patient care, but current diagnostic solutions often fail to deliver immediate, actionable guidance. There is an increasing need for tests that directly inform therapy decisions at or near the point of care.

We develop a drop-in chemistry for existing diagnostic devices. With one reagent swap, today’s platforms become next-generation molecular tests, enabling transformative upgrades without major new investment.